State of the Industry Episode 7: Automation Can Move Regenerative Medicine From the Lab To Production Part 1

What will it take to move highly specialized regenerative medicine – the engineering or regenerating human cells, tissues and organs – from the lab to production?  Manufacturing scalability, process and partnership.

The next breakthrough can help provide artificially produced tissues and even whole organs to people with serious injuries or diseases.

Learn more as Dave Vasko, director of advanced technology for Rockwell Automation, explores the future of biomanufacturing and the work of the Advanced Regenerative Manufacturing Institute and BioFabUSA with Dean Kamen, renown inventor and entrepreneur. Part one of a two-part series.

You can subscribe to the State of the Industry podcast on Apple iTunes.

Contact

We offer exceptional knowledge and service to help you design, implement, and support your automation investment.